203 related articles for article (PubMed ID: 19376280)
1. Estrogen-specific action on bone geometry and volumetric bone density: longitudinal observations in an adult with complete androgen insensitivity.
Taes Y; Lapauw B; Vandewalle S; Zmierczak H; Goemaere S; Vanderschueren D; Kaufman JM; T'Sjoen G
Bone; 2009 Aug; 45(2):392-7. PubMed ID: 19376280
[TBL] [Abstract][Full Text] [Related]
2. Skeletal effects of long-term estrogen and testosterone replacement treatment in a man with congenital aromatase deficiency: evidences of a priming effect of estrogen for sex steroids action on bone.
Rochira V; Zirilli L; Madeo B; Aranda C; Caffagni G; Fabre B; Montangero VE; Roldan EJ; Maffei L; Carani C
Bone; 2007 Jun; 40(6):1662-8. PubMed ID: 17400043
[TBL] [Abstract][Full Text] [Related]
3. Prevalent fractures are related to cortical bone geometry in young healthy men at age of peak bone mass.
Taes Y; Lapauw B; Griet V; De Bacquer D; Goemaere S; Zmierczak H; Kaufman JM
J Bone Miner Res; 2010 Jun; 25(6):1433-40. PubMed ID: 20200932
[TBL] [Abstract][Full Text] [Related]
4. Role of the androgen receptor in skeletal homeostasis: the androgen-resistant testicular feminized male mouse model.
Vandenput L; Swinnen JV; Boonen S; Van Herck E; Erben RG; Bouillon R; Vanderschueren D
J Bone Miner Res; 2004 Sep; 19(9):1462-70. PubMed ID: 15312246
[TBL] [Abstract][Full Text] [Related]
5. [Study of bone mineral density in complete androgen insensitivity syndrome patients].
Tian QJ; Dai ZQ; Yu W; Tian JP; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):799-802. PubMed ID: 16412322
[TBL] [Abstract][Full Text] [Related]
6. Effect of protein supplementation during a 6-month strength and conditioning program on areal and volumetric bone parameters.
Ballard TL; Specker BL; Binkley TL; Vukovich MD
Bone; 2006 Jun; 38(6):898-904. PubMed ID: 16364710
[TBL] [Abstract][Full Text] [Related]
7. Sexual dimorphism in cortical bone size and strength but not density is determined by independent and time-specific actions of sex steroids and IGF-1: evidence from pubertal mouse models.
Callewaert F; Venken K; Kopchick JJ; Torcasio A; van Lenthe GH; Boonen S; Vanderschueren D
J Bone Miner Res; 2010 Mar; 25(3):617-26. PubMed ID: 19888832
[TBL] [Abstract][Full Text] [Related]
8. Body composition, volumetric and areal bone parameters in male-to-female transsexual persons.
Lapauw B; Taes Y; Simoens S; Van Caenegem E; Weyers S; Goemaere S; Toye K; Kaufman JM; T'Sjoen GG
Bone; 2008 Dec; 43(6):1016-21. PubMed ID: 18835591
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in parameters of bone strength in new recruits: beyond bone density.
Evans RK; Negus C; Antczak AJ; Yanovich R; Israeli E; Moran DS
Med Sci Sports Exerc; 2008 Nov; 40(11 Suppl):S645-53. PubMed ID: 18849870
[TBL] [Abstract][Full Text] [Related]
10. The estrogen receptor ligand ICI 182,780 does not impair the bone-sparing effects of testosterone in the young orchidectomized rat model.
Vandenput L; Swinnen JV; Van Herck E; Verstuyf A; Boonen S; Bouillon R; Vanderschueren D
Calcif Tissue Int; 2002 Mar; 70(3):170-5. PubMed ID: 11907714
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment.
Lanfranco F; Zirilli L; Baldi M; Pignatti E; Corneli G; Ghigo E; Aimaretti G; Carani C; Rochira V
Bone; 2008 Sep; 43(3):628-35. PubMed ID: 18590994
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the skeletal effects of the progestogens desogestrel and levonorgestrel in oral contraceptive preparations in young women: controlled, open, partly randomized investigation over 13 cycles.
Hartard M; Kleinmond C; Luppa P; Zelger O; Egger K; Wiseman M; Weissenbacher ER; Felsenberg D; Erben RG
Contraception; 2006 Nov; 74(5):367-75. PubMed ID: 17046377
[TBL] [Abstract][Full Text] [Related]
13. Altered bone mineral density in patients with complete androgen insensitivity syndrome.
Bertelloni S; Baroncelli GI; Federico G; Cappa M; Lala R; Saggese G
Horm Res; 1998; 50(6):309-14. PubMed ID: 9973670
[TBL] [Abstract][Full Text] [Related]
14. Androgens and the skeleton.
Lindberg MK; Vandenput L; Movèrare Skrtic S; Vanderschueren D; Boonen S; Bouillon R; Ohlsson C
Minerva Endocrinol; 2005 Mar; 30(1):15-25. PubMed ID: 15877010
[TBL] [Abstract][Full Text] [Related]
15. Bone steady-state is established at reduced bone strength after spinal cord injury: a longitudinal study using peripheral quantitative computed tomography (pQCT).
Frotzler A; Berger M; Knecht H; Eser P
Bone; 2008 Sep; 43(3):549-55. PubMed ID: 18567554
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of low bone mass in relation to estrogen treatment and body composition in male-to-female transsexual persons.
T'Sjoen G; Weyers S; Taes Y; Lapauw B; Toye K; Goemaere S; Kaufman JM
J Clin Densitom; 2009; 12(3):306-13. PubMed ID: 19121966
[TBL] [Abstract][Full Text] [Related]
17. Comparison of bone mineral density and body proportions between women with complete androgen insensitivity syndrome and women with gonadal dysgenesis.
Han TS; Goswami D; Trikudanathan S; Creighton SM; Conway GS
Eur J Endocrinol; 2008 Aug; 159(2):179-85. PubMed ID: 18463105
[TBL] [Abstract][Full Text] [Related]
18. Bone health in disorders of sex differentiation.
Bertelloni S; Baroncelli GI; Mora S
Sex Dev; 2010 Sep; 4(4-5):270-84. PubMed ID: 20820111
[TBL] [Abstract][Full Text] [Related]
19. Bone measurements by peripheral quantitative computed tomography (pQCT) in children with cerebral palsy.
Binkley T; Johnson J; Vogel L; Kecskemethy H; Henderson R; Specker B
J Pediatr; 2005 Dec; 147(6):791-6. PubMed ID: 16356433
[TBL] [Abstract][Full Text] [Related]
20. In-vitro characterization of androgen receptor mutations associated with complete androgen insensitivity syndrome reveals distinct functional deficits.
Werner R; Zhan J; Gesing J; Struve D; Hiort O
Sex Dev; 2008; 2(2):73-83. PubMed ID: 18577874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
